Others may need to avoid spicy and greasy foods almost completely
[5] Observational studies provide additional context but face methodological challenges: patients prescribed GLP-1 receptor agonists typically have more advanced metabolic disease, higher body mass index, and greater baseline pancreatitis risk than comparison groups
The second pathway -arrestin signalling via GLP-1R has over the past decade become the subject of intensive research into the mechanism of biased agonism (preference of one intracellular pathway over another by the same ligand)
The recent emergence of novel therapies that drive weight loss and improve glucose control have generated hope and expectation that these conditions ultimately will be controlled
In one study, people who took semaglutide lost an average of 15% of their body weight over the course of 68 weeks
In June, the American Society of Anesthesiologists issued guidance advising patients to skip daily weight-loss medications on the day of surgery and hold off on weekly injections for a week before any sedation procedures